These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 33518355)

  • 1. Pharmacokinetics and Safety of Extended-release Ranolazine in Korean and White Healthy Subjects.
    Yoo H; Lee SW; Yoon DY; Yoon SH; Cho JY; Yu KS; Jang IJ; Lee S
    Clin Ther; 2021 Mar; 43(3):526-534.e4. PubMed ID: 33518355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Safety, and Tolerability of Tedizolid Phosphate After Single-dose Administration in Healthy Korean Male Subjects.
    Kim Y; Kim A; Lee S; Choi SH; Lee DY; Song JS; Lee H; Jang IJ; Yu KS
    Clin Ther; 2017 Sep; 39(9):1849-1857. PubMed ID: 28865799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
    Kim HC; Yang E; Lee S; Oh J; Lee M; Lee C; Ha KS; Lee WS; Jang IJ; Yu KS
    Invest New Drugs; 2024 Feb; 42(1):80-88. PubMed ID: 38099989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetic, safety, and tolerability profiles of eslicarbazepine acetate are comparable between Korean and White subjects.
    Hwang S; Lee S; Kim E; Hwang I; Cho JY; Chung JY; Jang IJ; Oh J
    Clin Transl Sci; 2022 Sep; 15(9):2116-2126. PubMed ID: 35727711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic properties of the calcimimetic agent cinacalcet (KRN1493) in healthy male Korean subjects: a randomized, open-label, single ascending-dose, parallel-group study.
    Lee S; Gu N; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2012 May; 34(5):1160-9. PubMed ID: 22503212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic Interactions Between Gemigliptin and Metformin, and Potential Differences in the Pharmacokinetic Profile of Gemigliptin Between the Mexican and Korean Populations: A Randomized, Open-label Study in Healthy Mexican Volunteers.
    Conde-Carmona I; García-Medina S; Jiménez-Vargas JM; Martínez-Muñoz A; Lee SH
    Clin Ther; 2018 Oct; 40(10):1729-1740. PubMed ID: 30249366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
    Choi Y; Han H; Shin D; Lim KS; Yu KS
    Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ketoconazole on lobeglitazone pharmacokinetics in Korean volunteers.
    Sil Oh E; Ok Kim C; Kim KH; Kim YN; Kim C; Lee JI; Park MS
    Clin Ther; 2014 Jul; 36(7):1064-71. PubMed ID: 25047497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic comparisons between two formulations containing 100 mg of miglitol in healthy male Korean volunteers: a randomized, open-label, single-dose, two-period, two-sequence crossover bioequivalence study.
    Choi HG; Jeon JY; Im YJ; Kim Y; Jang H; Kang S; Kim KH; Chae SW; Lee SY; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):55-63. PubMed ID: 24290415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers.
    Darwish M; Yang R; Tracewell W; Robertson P; Bond M
    Clin Ther; 2015 Feb; 37(2):390-401. PubMed ID: 25542074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese.
    Choi Y; Yoon S; Matsumoto K; Ohta Y; Lee S; Yu KS; Jang IJ
    Drug Des Devel Ther; 2018; 12():1045-1051. PubMed ID: 29750017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus.
    Zack J; Berg J; Juan A; Pannacciulli N; Allard M; Gottwald M; Zhang H; Shao Y; Ben-Yehuda O; Jochelson P
    Clin Pharmacol Drug Dev; 2015 Mar; 4(2):121-9. PubMed ID: 27128216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic drug interaction between atorvastatin and ezetimibe in healthy Korean volunteers.
    Park J; Kim CO; Jin BH; Yang S; Park MS; Hong T
    Transl Clin Pharmacol; 2017 Dec; 25(4):202-208. PubMed ID: 32095476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis.
    Scoville BA; Segal JH; Salama NN; Heung M; Bleske BE; Eyler RF; Mueller BA
    Ren Fail; 2019 Nov; 41(1):118-125. PubMed ID: 30909832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of two intravenous formulations of antithrombin III: a two-way crossover study in healthy Korean subjects.
    Kim KA; Lim YY; Kim SH; Park JY
    Clin Ther; 2013 Nov; 35(11):1752-61. PubMed ID: 24094463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects
.
    Moon SJ; Yu KS; Jung J; Kim YI; Kim MG
    Int J Clin Pharmacol Ther; 2020 Jun; 58(6):354-362. PubMed ID: 32271144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
    Sikes C; Stark JG; McMahen R; Engelking D
    Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers.
    Xiao F; Zhang F; Zhang LL; Wei W
    Eur J Clin Pharmacol; 2018 Jan; 74(1):69-77. PubMed ID: 29051989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
    Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
    Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.